PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AUPH vs. NXT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AUPH and NXT is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

AUPH vs. NXT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aurinia Pharmaceuticals Inc. (AUPH) and Nextracker Inc (NXT). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2025February
17.31%
10.90%
AUPH
NXT

Key characteristics

Sharpe Ratio

AUPH:

0.96

NXT:

-0.33

Sortino Ratio

AUPH:

1.75

NXT:

-0.15

Omega Ratio

AUPH:

1.19

NXT:

0.98

Calmar Ratio

AUPH:

0.49

NXT:

-0.40

Martin Ratio

AUPH:

3.41

NXT:

-0.66

Ulcer Index

AUPH:

12.28%

NXT:

29.56%

Daily Std Dev

AUPH:

43.85%

NXT:

57.82%

Max Drawdown

AUPH:

-87.58%

NXT:

-48.61%

Current Drawdown

AUPH:

-76.03%

NXT:

-23.30%

Fundamentals

Market Cap

AUPH:

$1.14B

NXT:

$6.80B

EPS

AUPH:

-$0.15

NXT:

$4.05

PEG Ratio

AUPH:

0.00

NXT:

4.64

Total Revenue (TTM)

AUPH:

$175.27M

NXT:

$2.77B

Gross Profit (TTM)

AUPH:

$152.57M

NXT:

$1.04B

EBITDA (TTM)

AUPH:

$21.43M

NXT:

$745.16M

Returns By Period

In the year-to-date period, AUPH achieves a -11.69% return, which is significantly lower than NXT's 27.26% return.


AUPH

YTD

-11.69%

1M

2.59%

6M

17.31%

1Y

32.17%

5Y*

-17.24%

10Y*

8.30%

NXT

YTD

27.26%

1M

13.87%

6M

10.90%

1Y

-18.75%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AUPH vs. NXT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AUPH
The Risk-Adjusted Performance Rank of AUPH is 7272
Overall Rank
The Sharpe Ratio Rank of AUPH is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of AUPH is 7676
Sortino Ratio Rank
The Omega Ratio Rank of AUPH is 6969
Omega Ratio Rank
The Calmar Ratio Rank of AUPH is 6666
Calmar Ratio Rank
The Martin Ratio Rank of AUPH is 7474
Martin Ratio Rank

NXT
The Risk-Adjusted Performance Rank of NXT is 2929
Overall Rank
The Sharpe Ratio Rank of NXT is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of NXT is 2929
Sortino Ratio Rank
The Omega Ratio Rank of NXT is 2929
Omega Ratio Rank
The Calmar Ratio Rank of NXT is 2323
Calmar Ratio Rank
The Martin Ratio Rank of NXT is 3333
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AUPH vs. NXT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and Nextracker Inc (NXT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AUPH, currently valued at 0.76, compared to the broader market-2.000.002.000.76-0.33
The chart of Sortino ratio for AUPH, currently valued at 1.50, compared to the broader market-4.00-2.000.002.004.006.001.50-0.15
The chart of Omega ratio for AUPH, currently valued at 1.16, compared to the broader market0.501.001.502.001.160.98
The chart of Calmar ratio for AUPH, currently valued at 0.55, compared to the broader market0.002.004.006.000.55-0.40
The chart of Martin ratio for AUPH, currently valued at 2.69, compared to the broader market-10.000.0010.0020.0030.002.69-0.66
AUPH
NXT

The current AUPH Sharpe Ratio is 0.96, which is higher than the NXT Sharpe Ratio of -0.33. The chart below compares the historical Sharpe Ratios of AUPH and NXT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00SeptemberOctoberNovemberDecember2025February
0.76
-0.33
AUPH
NXT

Dividends

AUPH vs. NXT - Dividend Comparison

Neither AUPH nor NXT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AUPH vs. NXT - Drawdown Comparison

The maximum AUPH drawdown since its inception was -87.58%, which is greater than NXT's maximum drawdown of -48.61%. Use the drawdown chart below to compare losses from any high point for AUPH and NXT. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%SeptemberOctoberNovemberDecember2025February
-35.37%
-23.30%
AUPH
NXT

Volatility

AUPH vs. NXT - Volatility Comparison

The current volatility for Aurinia Pharmaceuticals Inc. (AUPH) is 10.42%, while Nextracker Inc (NXT) has a volatility of 17.51%. This indicates that AUPH experiences smaller price fluctuations and is considered to be less risky than NXT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February
10.42%
17.51%
AUPH
NXT

Financials

AUPH vs. NXT - Financials Comparison

This section allows you to compare key financial metrics between Aurinia Pharmaceuticals Inc. and Nextracker Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab